Your search returned 3 results.

Sort
Results
1.
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast. MedStar authors:
  • Gallagher, Christopher
PMID:
  • 37148492
Year: 2023
Citation:
  • Targeted Oncology. 18(3):321-326, 2023 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Letter
  • Observational Study
Form of publication:
  • Journal Article
All authors:
  • Brufsky A, Gallagher C
2.
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast. MedStar authors:
  • Gallagher, Christopher
PMID:
  • 37148492
Year: 2023
Citation:
  • Targeted Oncology. 18(3):321-326, 2023 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Letter
  • Observational Study
Form of publication:
  • Journal Article
All authors:
  • Brufsky A, Gallagher C
3.
The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma. MedStar authors:
  • Abdussamad, Maryam
  • Zapas, John
  • Zhou, Hengbo
PMID:
  • 28157711
Year: 2017
Citation:
  • Oncotarget. 8(8):12576-12595, 2017 Feb 21
Institution:
  • MedStar Franklin Square Medical Center
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Abdussamad M, Atkins MB, Byers SW, Calvert V, Chen YS, Dakshanamurthy S, Fang HB, Gaur A, Petricoin EF, Rosenthal DS, Simbulan-Rosenthal CM, Zapas J, Zhou H
Pages

Powered by Koha